IMUC
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Jul 22 closing price
Capitalization
9.87M
VNDA
Price
$4.84
Change
+$0.13 (+2.76%)
Updated
Jul 23 closing price
Capitalization
285.24M
Earnings call today
Interact to see
Advertisement

IMUC vs VNDA

Header iconIMUC vs VNDA Comparison
Open Charts IMUC vs VNDABanner chart's image
EOM Pharmaceutical Holdings
Price$0.08
Change-$0.00 (-0.00%)
Volume$25.47K
Capitalization9.87M
Vanda Pharmaceuticals
Price$4.84
Change+$0.13 (+2.76%)
Volume$465.18K
Capitalization285.24M
IMUC vs VNDA Comparison Chart in %
Loading...
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUC vs. VNDA commentary
Jul 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUC is a Buy and VNDA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 24, 2025
Stock price -- (IMUC: $0.08 vs. VNDA: $4.71)
Brand notoriety: IMUC and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUC: 1038% vs. VNDA: 79%
Market capitalization -- IMUC: $9.87M vs. VNDA: $277.58M
IMUC [@Biotechnology] is valued at $9.87M. VNDA’s [@Biotechnology] market capitalization is $277.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $284.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUC’s FA Score shows that 1 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • IMUC’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, VNDA is a better buy in the long-term than IMUC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUC’s TA Score shows that 4 TA indicator(s) are bullish while VNDA’s TA Score has 3 bullish TA indicator(s).

  • IMUC’s TA Score: 4 bullish, 1 bearish.
  • VNDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IMUC is a better buy in the short-term than VNDA.

Price Growth

IMUC (@Biotechnology) experienced а +0.92% price change this week, while VNDA (@Biotechnology) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.00%. For the same industry, the average monthly price growth was +21.16%, and the average quarterly price growth was +30.92%.

Reported Earning Dates

VNDA is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Biotechnology (+7.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($285M) has a higher market cap than IMUC($9.87M). VNDA has higher P/E ratio than IMUC: VNDA (137.00) vs IMUC (0.02). VNDA YTD gains are higher at: -1.670 vs. IMUC (-53.791). VNDA has more cash in the bank: 341M vs. IMUC (85.3K).
IMUCVNDAIMUC / VNDA
Capitalization9.87M285M3%
EBITDAN/A-64.56M-
Gain YTD-53.791-1.6703,221%
P/E Ratio0.02137.000%
RevenueN/A201M-
Total Cash85.3K341M0%
Total DebtN/A11.7M-
FUNDAMENTALS RATINGS
IMUC vs VNDA: Fundamental Ratings
IMUC
VNDA
OUTLOOK RATING
1..100
2964
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
9557
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMUC's Valuation (9) in the Biotechnology industry is significantly better than the same rating for VNDA (84). This means that IMUC’s stock grew significantly faster than VNDA’s over the last 12 months.

IMUC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VNDA (100). This means that IMUC’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (93) in the Biotechnology industry is in the same range as IMUC (100). This means that VNDA’s stock grew similarly to IMUC’s over the last 12 months.

VNDA's Price Growth Rating (57) in the Biotechnology industry is somewhat better than the same rating for IMUC (95). This means that VNDA’s stock grew somewhat faster than IMUC’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for IMUC (100). This means that VNDA’s stock grew significantly faster than IMUC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMUCVNDA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 10 days ago
60%
Bullish Trend 7 days ago
71%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 3 days ago
68%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRVCF0.030.01
+23.87%
PreveCeutical Medical Inc.
ANZFF0.35N/A
N/A
Air New Zealand Ltd.
CHEOF193.04N/A
N/A
CochLear Ltd.
CCARF1.18-0.02
-1.67%
Colonial Coal International Corp
CFTN0.09N/A
-3.76%
Clifton Mining Co.

IMUC and

Correlation & Price change

A.I.dvisor tells us that IMUC and ANEB have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMUC and ANEB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUC
1D Price
Change %
IMUC100%
N/A
ANEB - IMUC
23%
Poorly correlated
+1.67%
VNDA - IMUC
22%
Poorly correlated
+1.07%
STTK - IMUC
21%
Poorly correlated
+4.52%
CCCC - IMUC
21%
Poorly correlated
-2.20%
PRTA - IMUC
8%
Poorly correlated
+3.82%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with AVIR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then AVIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+1.07%
AVIR - VNDA
44%
Loosely correlated
N/A
OCUL - VNDA
42%
Loosely correlated
+0.30%
CLDX - VNDA
41%
Loosely correlated
+1.36%
EYPT - VNDA
40%
Loosely correlated
-0.85%
PGEN - VNDA
40%
Loosely correlated
-16.94%
More